James E. Ousley - 01 Nov 2021 Form 4 Insider Report for Identiv, Inc. (INVE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Nov 2021, 20:18:40 UTC
Prior SEC filing
29 Oct 2021
Next SEC filing
30 Nov 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ed Kirnbauer, Attorney in Fact

Key filing fact

James E. Ousley filed Form 4 for Identiv, Inc. (INVE) on 03 Nov 2021.

Key facts

  • This page summarizes James E. Ousley's Form 4 filing for Identiv, Inc. (INVE).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Nov 2021, 20:18.

Change

  • Previous filing in this sequence was filed on 29 Oct 2021.
  • Current net transaction value: -$345,995.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INVE transaction

Common Stock

Sale

Transaction value
$108,100
Shares
-5,555
Change %
-2.3%
Price
$19.46
Shares after
238,887
Date
01 Nov 2021
Ownership
Direct
Footnotes
F1, F2, F3, F7
INVE transaction

Common Stock

Sale

Transaction value
$107,100
Shares
-5,555
Change %
-2.3%
Price
$19.28
Shares after
233,332
Date
02 Nov 2021
Ownership
Direct
Footnotes
F1, F2, F4, F7
INVE transaction

Common Stock

Sale

Transaction value
$126,080
Shares
-5,356
Change %
-2.3%
Price
$23.54
Shares after
227,976
Date
03 Nov 2021
Ownership
Direct
Footnotes
F1, F2, F5, F7
INVE transaction

Common Stock

Sale

Transaction value
$4,714
Shares
-200
Change %
-0.09%
Price
$23.57
Shares after
227,776
Date
03 Nov 2021
Ownership
Direct
Footnotes
F1, F2, F6, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.

Footnote F2

Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold.

Footnote F3

Represents a weighted average price. Actual sale prices ranged from $19.25 to $19.66.

Footnote F4

Represents a weighted average price. Actual sale prices ranged from $18.82 to $19.64.

Footnote F5

Represents a weighted average price. Actual sale prices ranged from $22.29 to $23.00.

Footnote F6

Represents a weighted average price. Actual sale prices ranged from $23.33 to $23.81

Footnote F7

Includes an aggregate of 3,647 shares of common stock issuable pursuant to Restricted Stock Unit awards that have not vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .